Jane Street Group, LLC Amgen Inc Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $335 Million - $365 Million	1,081,300 New	1,081,300 $348 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $196 Million - $217 Million	893,000 Added 295.89%	1,194,800 $289 Million
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $457,424 - $523,480	-2,300 Reduced 0.76%	301,800 $67.9 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $112 Million - $131 Million	-528,500 Reduced 63.48%	304,100 $64.7 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $164 Million - $181 Million	700,000 Added 527.9%	832,600 $203 Million
Q1 2021 May 18, 2021	SELL	$221.91 - $258.6 $28.9 Million - $33.6 Million	-130,100 Reduced 49.52%	132,600 $33 Million
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $24.6 Million - $29.3 Million	-113,700 Reduced 30.21%	262,700 $60.4 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $34.5 Million - $38.3 Million	146,900 Added 64.01%	376,400 $95.7 Million
Q2 2020 Aug 17, 2020	BUY	$197.81 - $242.74 $32.1 Million - $39.4 Million	162,300 Added 241.52%	229,500 $54.1 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $2.72 Million - $3.6 Million	14,900 Added 28.49%	67,200 $13.6 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $6.3 Million - $8.1 Million	-33,300 Reduced 38.9%	52,300 $12.6 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $3.38 Million - $4.05 Million	-19,400 Reduced 18.48%	85,600 $16.6 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $1.5 Million - $1.76 Million	-9,000 Reduced 7.89%	105,000 $19.4 Million
Q1 2019 May 16, 2019	BUY	$180.87 - $203.88 $4.83 Million - $5.44 Million	26,700 Added 30.58%	114,000 $21.7 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $3.32 Million - $3.87 Million	18,600 Added 27.07%	87,300 $17 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $2.54 Million - $2.86 Million	13,700 Added 24.91%	68,700 $14.2 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $4.93 Million - $5.54 Million	-29,700 Reduced 35.06%	55,000 $10.2 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $3.3 Million - $3.86 Million	19,500 Added 29.91%	84,700 $14.4 Million
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $14.8 Million - $16.6 Million	-87,900 Reduced 57.41%	65,200 $11.3 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $25.6 Million - $29.2 Million	153,100	153,100 $28.5 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account